(Q43807904)

27 November 2017

Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer (English)

1 reference

27 November 2017

1 reference

Y J Fang

1

1 reference

27 November 2017

Z H Lu

2

1 reference

27 November 2017

G Q Wang

3

1 reference

27 November 2017

Z Z Pan

4

1 reference

27 November 2017

Z W Zhou

5

1 reference

27 November 2017

J P Yun

6

1 reference

27 November 2017

M F Zhang

7

1 reference

27 November 2017

D S Wan

8

1 reference

27 November 2017

7 May 2009

1 reference

International Journal of Colorectal Disease

27 November 2017

1 reference

27 November 2017

24

1 reference

27 November 2017

8

1 reference

27 November 2017

875-884

1 reference

https://scigraph.springernature.com/pub.10.1007/s00384-009-0725-z

27 November 2017

0 references

cites work

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00384-009-0725-Z

Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?

21 January 2018

1 reference

12 December 2020

Cellular localisation of Survivin: impact on the prognosis in colorectal cancer

1 reference

12 December 2020

Molecular staging for survival prediction of colorectal cancer patients

1 reference

12 December 2020

Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas

1 reference

12 December 2020

Survivin study: what is the next wave?

1 reference

12 December 2020

Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

1 reference

12 December 2020

Minireview: Cyclin D1: normal and abnormal functions

1 reference

12 December 2020

Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.

1 reference

12 December 2020

Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases

1 reference

12 December 2020

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

1 reference

12 December 2020

New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression

1 reference

12 December 2020

Connecting proliferation and apoptosis in development and disease

1 reference

12 December 2020

Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma

1 reference

12 December 2020

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

1 reference

12 December 2020

Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2

1 reference

12 December 2020

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

1 reference

12 December 2020

High Pin1 expression is associated with tumor progression in colorectal cancer

1 reference

12 December 2020

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma

1 reference

12 December 2020

Tissue microarrays for gene amplification surveys in many different tumor types.

1 reference

12 December 2020

Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies

1 reference

12 December 2020

Matrilysin is associated with progression of colorectal tumor

1 reference

12 December 2020

Tumour markers of prognosis in colorectal cancer

1 reference

12 December 2020

Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation

1 reference

12 December 2020

Predictive and prognostic markers in gastrointestinal cancers

1 reference

12 December 2020

Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression

1 reference

12 December 2020

Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer

1 reference

12 December 2020

Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1.

1 reference

12 December 2020

Cell division and cell survival in the absence of survivin

1 reference

12 December 2020

Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

Role of matrix metalloproteinase-7 in colorectal adenomas.

1 reference

12 December 2020

Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma

1 reference

12 December 2020

High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection

1 reference

12 December 2020

Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.

1 reference

12 December 2020

Clinical significance of TROP2 expression in colorectal cancer

1 reference

12 December 2020

1 reference

12 December 2020

Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis

1 reference

12 December 2020

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

1 reference

12 December 2020

Expression of maspin in colorectal cancer

1 reference

12 December 2020

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

1 reference

12 December 2020

How matrix metalloproteinases regulate cell behavior

1 reference

12 December 2020

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

12 December 2020

Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.

1 reference

12 December 2020

TGF beta signaling in health and disease

1 reference

12 December 2020

Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis

1 reference

12 December 2020

MRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers

1 reference

12 December 2020

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

12 December 2020

Molecular causes of colon cancer

1 reference

12 December 2020

Human trophoblast cell-surface antigens defined by monoclonal antibodies

1 reference

12 December 2020

Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.

1 reference

12 December 2020

p53: link to the past, bridge to the future

1 reference

12 December 2020

Pathways of apoptotic and non-apoptotic death in tumour cells

1 reference

12 December 2020

Report of the fifth international workshop on human chromosome 1 mapping 1999.

1 reference

12 December 2020

Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2

1 reference

12 December 2020

Surfing the p53 network

1 reference

12 December 2020

Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis

1 reference

12 December 2020

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

12 December 2020

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

1 reference

12 December 2020

Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery

1 reference

12 December 2020

Validating survivin as a cancer therapeutic target

1 reference

12 December 2020

The application of tissue microarrays to cancer research

1 reference

12 December 2020

10.1007/S00384-009-0725-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference